The company is evaluating whether Cellular Origins’ Constellation automation platform can be used in selected Immatics manufacturing steps to improve consistency, efficiency, and scalability for next-generation cancer cell therapies.
Regeneron said it will reduce Medicaid and future U.S. drug prices in line with other developed countries, enable direct discounted purchases of Praluent through TrumpRx.gov, and continue investing in domestic R&D and...
Mesoblast has secured exclusive global rights to a CAR technology platform to engineer its MSC therapies for more precise targeting and greater potency in inflammatory and autoimmune diseases, including bowel disease and...
This marks Taiwan’s first GMP facility with mRNA and nucleic acid manufacturing capabilities to expand its CRDMO services and support advanced therapies from development through commercial production.
Pluripotent stem cell therapies are expensive, upwards of $500K–$1M per dose. Mytos has developed an automated manufacturing platform to bring that down, it's currently being used by many companies, including Aspen Neuroscience...
The Geneva site upgrade will expand Bracco’s GMP production capacity for its microbubble-based cell selection and activation platform, aiming to simplify cell therapy manufacturing and support clinical availability by mid-2027.
Gallant is betting the future of veterinary regenerative medicine lies in scalable, well-characterized cell therapies. By sourcing mesenchymal stem cells from uterine tissue collected during routine spays, it has built an off-the-shelf...
Exo-Top and BioXtek have signed a non-binding letter of intent to explore a partnership focused on GMP manufacturing, clinical supply, and potential commercialization of bone marrow-derived mesenchymal stem cell exosomes.
South Korea’s KDCA has begun distributing the nation’s first clinical-grade induced pluripotent stem cell lines, a move expected to cut costs and speed development of artificial blood and other cell-based therapies.
Longeveron has received a Chinese patent covering potency assay methods used to assess human mesenchymal stem cells from multiple tissue sources and induced pluripotent stem cells, extending the company’s patent rights in...
